Boussard & Gavaudan Investment Management »

Cytokinetics shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $555k 18k 30.24
2023-06-30 $517k 16k 33.23

More positions owned by Boussard & Gavaudan Investment Management

Activision Blizzard
Horizon Therapeutics Pub L SHS
Chart Inds Note 1.000%11/1
Vmware Cl A Com
Seagen
Cnx Res Corp Note 2.250% 5/0
Booking Holdings Note 0.750% 5/0
Altair Engr Note 0.250% 6/0
Permian Resources Corp Note 3.250% 4/0
On Semiconductor Corp Note 5/0
Westrock (WRK)
Bgc Group Cl A (BGC)
Ambac Finl Group Com New (AMBC)
Cinemark Hldgs Note 4.500% 8/1
Dynavax Technologies Corp Note 2.500% 5/1

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics